Egr-1 is an immediate early gene that couples short-term changes in the extracellular milieu to long-term changes in gene expression. Under in vitro conditions, the Egr-1 gene is expressed in many cell types and is induced by a wide variety of extracellular signals. The mechanisms by which the Egr-1 gene is regulated in vivo remain poorly understood. In this study, we have generated transgenic mice with a construct containing 1200 bp of the mouse Egr-1 promoter coupled to nuclear localized LacZ. In multiple independent lines of mice, reporter gene expression was detected in subsets of endothelial cells, vascular smooth-muscle cells, cardiomyocytes, neurons, and hepatocytes. This pattern closely resembled that of the endogenous gene. After partial hepatectomy, reporter gene activity was upregulated between two-and fivefold in regenerating livers. Taken together, these findings suggest that the Egr-1 promoter contains information for appropriate spatial and temporal expression in vivo.
Although Egr-1 has been implicated in the transcriptional regulation of many genes, the mechanisms by which the Egr-1 gene is itself regulated remain poorly understood. In transient transfection assays, the upstream promoter region has been shown to transduce both mitogenic and nonmitogenic signals. In cultured cells, the environmentally responsive DNA elements have typically been mapped to serum response elements (SREs) in the 5' flanking region (12, (16) (17) (18) . However, the role of the SREs or other regulatory elements in mediating inducible gene expression has yet to be demonstrated under in vivo conditions.
The overall aim of this study was to determine whether the upstream promoter region of the Egr-1 gene contained information for appropriate expression in the intact animal. To that end, we have generated transgenic mice with a DNA construct containing 1200 bp of the mouse promoter coupled to a nuclear localized LacZ reporter gene. We show that the Egr-1 promoter contains information for basal expression in subpopulations of endothelial cells, vascular smooth muscle cells, cardiomyocytes, neurons, and hepatocytes in a pattern that is similar to that of the endogenous Egr-1 gene. Furthermore, we demonstrate that in hepatocytes, the Egr-1 promoter confers response to proliferative stimuli after partial hepatectomy. Taken together, these results suggest that the transgenic mouse assay will serve as a useful model system for studying immediate-early gene regulation.
MATERIALS AND METHODS

Mouse protocols
All protocols were approved by the Institutional Animal Care and Use Committee of the Beth Israel Deaconess Medical Center.
Generation and analysis of transgenic mice
A 1200-bp fragment of the mouse Egr-1 promoter was PCR amplified from mouse genomic DNA, coupled to SalI linkers, and cloned into the pBluescript vector (Stratagene, La Jolla, CA). After the DNA sequence was verified, the promoter fragment was cloned into pnLacF, which is a plasmid that contains the nuclear localized β-galactosidase reporter gene, a human growth hormone intron and a poly(A) tail. The resulting construct was digested with Not1 and Xho1 to release a fragment containing the Egr-1 promoter region coupled to nuclear localized LacZ. The DNA fragment was separated from vector sequences by agarose gel electrophoresis as previously described (19) . Microinjections of fertilized mouse eggs and oviduct transfer techniques were carried out as previously described (19) . Founder mice were identified by Southern blot analysis and mated with wild-type FVB mice to generate stable lines of transgenic mice. Whole-mount staining of adult transgenic animals was carried out as previously described (19) . Tissues from heterozygous adult offspring were perfused with paraformaldehyde-containing solution, embedded in OCT compound, and quickly frozen on dry ice. Frozen sections of 10 µm were collected in a cryostat, attached to polylysinecoated slides, and incubated in a solution containing 5-bromo-4-chloro-3-indolyl-(-Dgalactopyranoside (X-Gal) for 24 h at 30°C as previously described (19) . For colocalization studies with von Willebrand factor (vWF), tissue sections from the hearts and brains of adult transgenic mice were stained with X-Gal overnight, washed extensively with PBS, and then processed for immunoperoxidase detection of vWF as previously described (19) .
For immunofluorescent detection of LacZ or Egr-1, frozen sections were post-fixed in acetone at 4° C for 10 min, washed three times in PBS, then incubated with DAKO protein block serum-free solution (DAKO, Carpinteria, CA) for 20 min at room temperature. The sections were then co-incubated with a rabbit polyclonal anti-Egr-1 antibody (Santa Cruz Biotechnology, Santa Cruz, CA; 1:100 dilution) or a rabbit antibody to E. coli β-galactosidase (5 primeAE3 prime, Inc., Boulder, CO) and a rat monoclonal anti-CD31 antibody (PharMingen, San Diego, CA; 1:200 dilution) for 60 min at room temperature. Sections were washed three times in PBS, then incubated with a Cy3-conjugated goat anti-rabbit IgG (Zymed, South San Francisco, CA; 1:50 dilution) and FITC-conjugated goat anti-rat IgG (Vector, Burlingame, CA; 1:50 dilution) for 30 min at room temperature. After extensive washing in PBS, slides were mounted with DAPI/Antifade (Oncor, Gaithersburg, MD). Confocal images were obtained with a BioRad MRC 1024 confocal laser scanning microscope.
Partial hepatectomy
Partial hepatectomies were performed as previously described (20) . Briefly, Egr-1 transgenic mice were anaesthetized with ketamine/xyline (1.8/0.2 mg). A midline incision was performed between the xiphoid process and the midabdomen, exposing the liver. The left lateral and anterior lobes were ligated at the hila and excised en bloc. Parts of the excised liver were processed for whole mount LacZ staining as well as protein and RNA extraction (see below). The abdomen was closed in two layers with nylon suture and the animals were returned to their cages where they were cared for according to standard procedures. At various time points after the surgery, the mice were killed and the right lobe of the liver was removed for LacZ staining and RNA and protein extraction.
RT-PCR analysis of Egr-1 and LacZ expression
Total RNA was prepared from the liver by guanidine thiocyanate-phenol-chloroform extraction (Stratagene). Random-primed first-strand cDNA synthesis was prepared from J RI WRWDO 51$ XVLQJ WKH 6XSHUVFULSW 3UHDPSOLILFDWLRQ 6\VWHP /LIH 7HFKQRORJLHV according to the manufacturer's instructions. One-tenth of the first-strand cDNA was then amplified by PCR with primer sets specific for LacZ (sense, 5'-ACGTAACCTATCCCATTACGGTCAATC;
antisense, 5'-AATATTGGCTTCATCCACCACATACAG) and β-actin (Clontech, Palo Alto, CA) (sense, 5'-GTGGGCCGCTCTAGG CACCAA; antisense, 5'-CTCTTTGATGTCACGCACGATTTC). The PCR condition for LacZ was 95°C for 3 min, 30 cycles of 95°C for 1 min, 68°C for 3 min, followed by a final incubation of 7 min at 72°C. One-fifth of the PCR products was electrophoresed on a 1.2% agarose gel and visualized by ethidium bromide staining.
β-Galactosidase assays
Liver pieces excised from mice were frozen in liquid nitrogen, homogenized in lysis buffer (100 mM potassium phosphate, pH 7.8, 0.2% Triton X-100) (Tropix, Bedford, MA), plus 0.5 mM PMSF, and a protease inhibitor cocktail (Boehringer Mannheim), and incubated on ice for 2 h. The lysates were clarified by centrifugation at 10,000g for 30 min and the cell debris was removed. Protein quantitation was carried out with the microprotein determination system (Sigma). β-galactosidase activity was assayed using the Galacto-Star chemiluminescent reporter assay system (Tropix), according to the manufacturer's instructions. Light units were normalized to protein concentration and to endogenous β-galactosidase activity from wild-type FVB mouse livers.
RESULTS
The Egr-1 transgene is expressed in a subset of organs and cell types
A total of nine founder lines were generated with the Egr-1-lacZ construct. Of these nine lines, three revealed LacZ expression. Whole-mount staining of all three lines revealed similar patterns of transgene expression. LacZ staining was detected at the ostia of aortic tributaries (Fig. 1a) , in blood vessels of the brain and heart (Fig. 1b-e) , and in the liver (Fig. 1h, i) . In contrast, there was no LacZ staining in whole mounts of the lung (Fig. 1f) or spleen (Fig. 1g) . Tissue sections were obtained from two of the lines and revealed similar patterns of β-galactosidase activity. In sections of the brain, the X-Gal reaction product was present within a subset of neurons and in a subpopulation of endothelial cells and vascular smooth-muscle cells lining the large arteries of the subarachnoid and subpial space (Fig. 2a-c) . In the heart, expression was detected in a minority of endothelial cells lining the capillaries of the myocardial wall and the large coronary arteries (Fig. 2d, e) . The X-Gal reaction product was also detected in occasional cardiomyocytes and vascular smooth-muscle cells (not shown). β-galactosidase activity in the liver appeared to be confined to hepatocytes (Figs. 2f-h ). Despite the seemingly organized mosaic pattern of β-galactosidase activity in liver whole mounts, LacZ-positive hepatocytes were randomly scattered throughout the three acinar zones. Reporter gene expression was not detected in tissue sections of the lung (Fig. 2i) , skeletal muscle (Fig.  2j) , kidney (Fig. 2k) , or spleen (Fig. 2l) .
The Egr-1 transgene is expressed in a pattern similar to that of the endogenous gene
In immunofluorescent studies, endogenous Egr-1, and the LacZ antigen were present in a minority of endothelial cells within the capillaries and coronary arteries of the heart (Fig.  3a, b shows Egr-1-positive microvascular endothelial cells; Figs. 4a and 5a, b reveal nuclear LacZ in the same cell type). In addition, Egr-1 was detected in a small number of cardiomyocytes ( Fig. 3c shows an Egr-1-positive cell) and vascular smooth-muscle cells of the heart (not shown). In the liver, the Egr-1 and LacZ gene products were present in a subpopulation of hepatocytes as well as occasional sinusoidal endothelial cells (Figs. 3d,  4b, 5d ). In the cortex of the brain, Egr-1 and LacZ were expressed in endothelial cells of the superficial arteries (Figs. 3e, 4c, 5c ) and in a subpopulation of neurons within the cortex and hippocampus (Figs. 3f and 4d show Egr-1 and LacZ immunoreactivity from serial sections of the cortex). Immunodetectable Egr-1, but not LacZ, was rarely found in endothelial cells of pulmonary and splenic arteries (not shown). The presence of Egr-1 in these vascular beds was far less common than in the heart, brain, and liver.
To provide additional evidence that the Egr-1 transgene is expressed in endothelial cells, tissue sections from the heart and brain of adult transgenic mice were stained with X-Gal and then processed for immunoperoxidase detection of vWF. As shown in Figure 6 , nuclear LacZ staining was present in vWF-positive endothelial cells of subarachnoid and coronary arteries.
The Egr-1 transgene is induced after partial hepatectomy
In previous studies, the endogenous Egr-1 gene has been shown to be induced in response to partial hepatectomy (21) (22) (23) . To determine whether the Egr-1 transgene contained information for this response, partial hepatectomies were carried out in Egr-1-lacZ transgenic mice. Because liver specimens were harvested at the time of the hepatectomy and at some time after hepatectomy, each animal had its own prehepatectomy control. As shown in Figure 7A , LacZ mRNA was significantly induced 24 and 48 h after partial hepatectomy. Egr-1 transcripts were increased at 24 h and normalized by 48 h (Fig. 7A) . The discrepancy between LacZ and Egr-1 response at 48 h may reflect differences in the half-life of the respective messages. The X-Gal reaction product was up-regulated in post-hepatectomy whole mounts (Fig. 7B, panels a, b) . LacZ staining of post-hepatectomy liver sections revealed increased intensity of β-galactosidase activity in hepatocytes and an increased number of LacZ-positive hepatocytes (Fig. 7B, panels c-f) . The LacZ-positive cells appeared to be randomly distributed throughout the hepatic nodules. Immunofluorescent studies of posthepatectomy liver sections revealed increased levels of endogenous Egr-1 protein in hepatocytes (Fig. 7C) . Finally, in quantitative assays, β-galactosidase activity was induced between two-and five-fold 1-3 days after partial hepatectomy (Fig. 7D) . In contrast, partial hepatectomy did not induce endogenous β-galactosidase activity in the liver of nontransgenic control mice between 4 h and 3 days (not shown). These findings demonstrate that the response of the Egr-1 gene during liver regeneration is mediated by transcriptional control elements in the 5' flanking region of the gene.
DISCUSSION
Egr-1 is a nuclear signal transducer that couples short-term changes in the extracellular milieu to long-term changes in gene expression. Under in vitro conditions, the Egr-1 gene has been shown to be expressed in multiple cell types and is induced by a variety of extracellular cues. For example, Egr-1 is up-regulated in renal tubular cells by urea (12) , in NIH 3T3 fibroblasts by heat shock and serum (24) , in mesangial cells by PDGF-BB and angiotensin II (25) , in smooth-muscle cells by PDGF-BB and thrombin (26) , in osteoblast cells by EGF (27) , and in endothelial cells by bFGF, aFGF, and shear stress (16, (28) (29) (30) . Surprisingly, little is known about the tissue distribution of Egr-1 in the intact animal. Using immunofluorescent assays, we have shown that the Egr-1 gene is constitutively expressed in endothelial cells, vascular smooth-muscle cells, cardiomyocytes, neuronal cells, and hepatocytes of the adult mouse. A striking feature of the present study was the marked heterogeneity of Egr-1 expression. For example, in sections of the myocardial wall, only a small minority of microvascular endothelial cells and cardiomyocytes contained immunoreactive Egr-1 protein. There are several possible explanations for the heterogeneous distribution of Egr-1. Some subpopulations of cells may be genetically preprogrammed to express the Egr-1 gene. In certain lineages, such as cardiomyocytes and neurons, Egr-1 levels may correlate with the state of cellular differentiation (2). Finally, variation in Egr-1 levels among neighboring cells may reflect differences in signal input at the level of the microenvironment.
In cell culture systems, the upstream region of the Egr-1 promoter has been shown to transduce extracellular signals. The Egr-1 promoter contains 5 functional SRE sites that are organized into two clusters. The 5' SRE cluster has been shown to mediate Egr-1 response to shear stress, growth hormone, urea, and hypotonicity (12, (16) (17) , whereas the 3' SRE cluster plays a predominant role in transducing response to granulocyte macrophage-colony stimulating factor (18) . All 5 SREs play a more equal role in mediating response to PDGF-BB (31). These results suggest that the SREs act in unique combinations to transduce extracellular signals in different cell types. If operative in vivo, this regulatory mechanism might provide a means for directing cell type-specific and extracellular signal-specific expression of the Egr-1 gene.
Previous studies have not addressed the role of the SRE and/or other upstream transcriptional control elements in mediating physiological expression of the Egr-1 gene. In the current report, we show that the 1200-bp Egr-1 promoter directs expression in subsets of endothelial cells, cardiomyocytes, hepatocytes, and neurons in transgenic mice. Importantly, the spatial distribution of β-galactosidase activity correlated with that of the endogenous gene. In serial sections, Egr-1-positive and LacZ-positive cells were derived from similar populations. Moreover, similar to the endogenous gene, the reporter gene was expressed in a minority of cells within the various lineages. Co-localization studies were not carried out for two reasons. First, the Egr-1 and the β-galactosidase polyclonal antibodies are both rabbit-derived and therefore are not amenable to doublelabeling of the same tissue section. Secondly, if Egr-1 and LacZ mRNA and protein are differentially processed, as would be expected from the relatively rapid turnover of Egr-1, the two gene products would not consistently co-localize. These limitations notwithstanding, the present results strongly suggest that the 1200-bp promoter fragment contains information for appropriate spatial expression.
To test whether the Egr-1 promoter contained information for environmental induction and temporal regulation, we used a partial hepatectomy model. The loss of hepatic tissue provides a powerful stimulus for cellular proliferation (32) . After two-thirds hepatectomy, normally quiescent liver cells are stimulated to re-enter the cell cycle and proliferate to restore the original liver mass. During this process, Egr-1 and other immediate early genes are rapidly activated (21) (22) (23) ). In the current report, we have demonstrated that the partial hepatectomy-mediated response of the Egr-1 gene is transduced by sequences within the 1200-bp promoter region. Reporter gene activity and mRNA were increased above baseline after the procedure and remained elevated for 72 h. In liver sections stained with X-Gal, there was an increase both in the number of expressing hepatocytes and in the degree of staining per hepatocyte. In other words, in response to partial hepatectomy, nonexpressing cells were recruited to express the transgene. These findings suggest that the 1200-bp promoter does indeed contain information for appropriate temporal regulation of the Egr-1 gene.
The Egr-1 transgene represents a novel molecular tool for studying immediate early gene regulation. The results of the present study support the conclusion derived from a myriad of in vitro studies, namely that the 1200-bp promoter region directs basal expression and is responsible for transducing extracellular signals. The transgenic mouse may be used to study the in vivo response of the promoter to other environmental modifications that are known to induce the endogenous Egr-1 gene, including ischemia/hypoxia (33) (34) (35) , epileptic seizures (36, 37) , visual stimulation (38, 39) , and endothelial cell injury (40) . Moreover, the LacZ reporter gene may serve as a useful marker in studies designed to dissect the pathways that mediate partial hepatectomy-induced expression of Egr-1 and other immediate early genes. Finally, the present investigation lays an important foundation for delineating the cis-regulatory elements in mediating inducible gene expression in vivo. By generating transgenic mice that harbor deletant promoter-reporter gene constructs, we will be in a position to determine the relative role of the 5 and 3' SREs and other transcriptional control elements in mediating physiological expression in constitutive and inducible states. Tissue cryosections were obtained from adult Egr-1-lacZ-#20 mice and processed for LacZ staining. In sections of the brain, the X-Gal reaction product was detected in endothelial cells (a, b) and smooth-muscle cells (b, artery on the left) of the subarachnoid and subpial blood arteries as well as a subset of neurons in the cerebral cortex (c). In the heart, expression was present within a minority of endothelial cells within the coronary arteries and myocardial capillaries (d, low-power; e, high-power). The reporter gene was expressed in a subpopulation of hepatocytes (f and g, low-power; h, high-power). There was no detectable β-galactosidase activity in the lung (i), skeletal muscle (j), kidney (k), or spleen (l). The faint blue stain in these latter organs represents background endogenous β-galactosidase activity. Tissue sections from adult Egr-1-lacZ-#20 mice were stained with X-Gal and processed for immunoperoxidase detection of vWF as previously described (19) . The X-Gal reaction product ( (panels a, b), 25 µm (panels c, d ). D) β-galactosidase activity of post-hepatectomy specimens was compared with the pre-hepatectomy controls and expressed as fold induction relative to levels of expression in the pre-hepatectomy liver. Each bar represents the average of duplicate samples from an individual animal. The results were obtained from Egr-1-lacZ-#20 mice with the exception of a single Egr-1-lacZ-#9 mouse (*).
